Clinical Trial

MaioRegen Prime Study for the Treatment of Deep Osteochondral Lesion of the Knee

Study acronym: OSTEOCONFIRM
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The present study aims to compare the efficacy and the safety of MaioRegen Prime to Debridement (SSOC) in patients with deep osteochondral lesions of the knee joint. The foreseen population involves patients with osteochondral lesions with different etiology, dimension, shape, and location. The evaluation will be performed through clinical, subjective and objective assessments.
Trial Details
NCT Number NCT07332182
Lead Sponsor Fin-Ceramica Faenza Spa
Conditions Osteochondral Lesions of the Knee Joint, Osteochondritis Dissecans (OCD), Early Osteoarthritis
Enrollment 400 participants
Start Date 2026-05
Primary Completion 2031-04-30 (estimated)
Study Completion 2031-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-12